Biofrontera Inc. (BFRIW) stock

BFRIWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BFRI

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30

$0.00+0.00 (0.00%)

Close on Oct 30, 2026Market cap $12.96MP/E –Yield –

Biofrontera EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Biofrontera's EPS for the twelve months ending Jun 30, 2026 was -$0.60. For fiscal 2025 it was -$1.04. The highest annual figure on record is -$0.61 in fiscal 2022.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$1.04	–
FY2024	Dec 31, 2024	-$3.22	–
FY2023	Dec 31, 2023	-$13.02	–
FY2022	Dec 31, 2022	-$0.61	–
FY2021	Dec 31, 2021	-$85.60	–
FY2020	Dec 31, 2020	-$9589.60	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	-$0.05	–
Q1 FY2026	Mar 31, 2026	-$0.41	–
Q4 FY2025	Dec 31, 2025	$0.48	–
Q3 FY2025	Sep 30, 2025	-$0.62	–
Q2 FY2025	Jun 30, 2025	-$0.57	–
Q1 FY2025	Mar 31, 2025	-$0.47	–
Q3 FY2024	Sep 30, 2024	-$0.98	–
Q2 FY2024	Jun 30, 2024	-$0.05	–
Q1 FY2024	Mar 31, 2024	-$2.88	–
Q3 FY2023	Sep 30, 2023	-$4.64	–
Q2 FY2023	Jun 30, 2023	-$7.23	-213.0%
Q1 FY2023	Mar 31, 2023	-$5.60	–
Q3 FY2022	Sep 30, 2022	-$2.26	–
Q2 FY2022	Jun 30, 2022	-$0.90	–
Q1 FY2022	Mar 31, 2022	$6.40	–
Q4 FY2021	Dec 31, 2021	-$25.83	–
Q3 FY2021	Sep 30, 2021	-$40.00	–
Q2 FY2021	Jun 30, 2021	-$9.20	–
Q1 FY2021	Mar 31, 2021	-$8.80	–
Q3 FY2020	Sep 30, 2020	-$59693.40	–